Adagene Inc.
ADAGNASDAQHealthcare● Active
$3.26
$-0.06(-1.81%)
Market Cap$122734429
P/E Ratio—
52W High$4.75
52W Low$1.3
Adagene Inc. (ADAG) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ADAG · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 1, 2026EPS Actual
-$0.07
Est. -$0.28 · +75.0%
Revenue
$0.01B
Est. $0.02B · -56.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 1, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
ADAG reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.03
Rev. $1.54B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.03
Rev. Est.$1.54B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 2, 2026 | -$0.22 | — | — | — | $0.02B | — |
| ▲ Q2 FY2026 | Apr 1, 2026 | -$0.28 | -$0.07 | +75.0% | $0.01B | $0.02B | -56.1% |
| ◌ Q1 FY2026 | Mar 23, 2026 | -$0.19 | — | — | — | $0.02B | — |
| ▼ Q1 FY2025 | Mar 24, 2025 | -$0.33 | -$0.55 | -67.7% | $0.00B | — | — |
| ▲ Q3 FY2024 | Jul 25, 2024 | -$0.41 | -$0.19 | +53.0% | — | — | — |
| — Q1 FY2024 | Mar 31, 2024 | — | -$0.19 | — | — | — | — |
| ▲ Q1 FY2024 | Mar 29, 2024 | -$0.42 | -$0.17 | +59.8% | $0.00B | — | — |
| — Q3 FY2023 | Sep 30, 2023 | — | -$0.17 | — | $0.00B | — | — |
Q3 FY2026
Sep 2, 2026
EPS Actual
—
EPS Est.
-$0.22
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 1, 2026Beat
EPS Actual
-$0.07
EPS Est.
-$0.28
EPS Surpr.
+75.0%
Revenue
$0.01B
Q1 FY2026
Mar 23, 2026
EPS Actual
—
EPS Est.
-$0.19
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 24, 2025Miss
EPS Actual
-$0.55
EPS Est.
-$0.33
EPS Surpr.
-67.7%
Revenue
$0.00B
Q3 FY2024
Jul 25, 2024Beat
EPS Actual
-$0.19
EPS Est.
-$0.41
EPS Surpr.
+53.0%
Revenue
—
Q1 FY2024
Mar 31, 2024
EPS Actual
-$0.19
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 29, 2024Beat
EPS Actual
-$0.17
EPS Est.
-$0.42
EPS Surpr.
+59.8%
Revenue
$0.00B
Q3 FY2023
Sep 30, 2023
EPS Actual
-$0.17
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-0.27 | $-0.27 | $-0.27 | 1 |
| Q3 FY2028 | $-0.27 | $-0.27 | $-0.27 | 1 |
| Q2 FY2028 | $-0.22 | $-0.22 | $-0.22 | 1 |
| Q1 FY2028 | $-0.28 | $-0.28 | $-0.28 | 1 |
| Q4 FY2027 | $-0.32 | $-0.32 | $-0.32 | 1 |
| Q3 FY2027 | $-0.33 | $-0.33 | $-0.33 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 1, 2026 | +75.0% | $3.92 | $4.61 | +17.60% |
| ▼ Q1 FY2025 | Mar 24, 2025 | -67.7% | $1.69 | $1.77 | +4.73% |
| ▲ Q3 FY2024 | Jul 25, 2024 | +53.0% | $2.74 | $2.53 | -7.66% |
| — Q1 FY2024 | Mar 31, 2024 | — | $2.80 | $3.24 | +15.71% |
| ▲ Q1 FY2024 | Mar 29, 2024 | +59.8% | $2.80 | $3.24 | +15.71% |
| — Q3 FY2023 | Sep 30, 2023 | — | $1.53 | $1.43 | -6.54% |
| ▲ Q3 FY2023 | Aug 31, 2023 | +87.6% | $1.18 | $1.36 | +15.25% |
| — Q1 FY2023 | Mar 31, 2023 | — | $1.45 | $1.45 | +0.00% |
Q2 FY2026+17.60%
Report Date
Apr 1, 2026
EPS Beat/Miss
+75.0%
Price Before
$3.92
Price After
$4.61
Q1 FY2025+4.73%
Report Date
Mar 24, 2025
EPS Beat/Miss
-67.7%
Price Before
$1.69
Price After
$1.77
Q3 FY2024-7.66%
Report Date
Jul 25, 2024
EPS Beat/Miss
+53.0%
Price Before
$2.74
Price After
$2.53
Q1 FY2024+15.71%
Report Date
Mar 31, 2024
EPS Beat/Miss
—
Price Before
$2.80
Price After
$3.24
Q1 FY2024+15.71%
Report Date
Mar 29, 2024
EPS Beat/Miss
+59.8%
Price Before
$2.80
Price After
$3.24
Q3 FY2023-6.54%
Report Date
Sep 30, 2023
EPS Beat/Miss
—
Price Before
$1.53
Price After
$1.43
Q3 FY2023+15.25%
Report Date
Aug 31, 2023
EPS Beat/Miss
+87.6%
Price Before
$1.18
Price After
$1.36
Q1 FY2023+0.00%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$1.45
Price After
$1.45
Avg Beat Reaction+10.23%
Avg Miss Reaction+4.73%
Beat Rate4 / 8 quarters
Largest Move+17.60% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ADAG ends December
Adagene Inc. (ADAG) most recently reported earnings on April 1, 2026 for Q2 FY2026, posting EPS of $-0.07 — beating the analyst consensus of $-0.28 by +75.0%. The next ADAG earnings date is expected around September 1, 2026.
Each quarter, investors track ADAG earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ADAG revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ADAG's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ADAG earnings · 5 questionsAdagene Inc.'s next earnings report is expected around September 1, 2026. ADAG typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ADAG historically reports after market close (AMC).
ADAG earnings datewhen is ADAG earningsADAG next earnings datewhen does ADAG report earningsADAG earnings calendar
▸ Source: FMP · Adagene Inc. SEC filings · US GAAP · Adagene Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026